Group One Trading
XERS icon

Group One Trading’s Xeris Biopharma Holdings XERS Stock Holding History

Group One Trading’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
226,607
+8,462
+4% +$54K ﹤0.01% 2322
2026
Q1 		$1.27M Buy
218,145
+94,584
+77% +$627K ﹤0.01% 2485
2025
Q4 		$970K Buy
123,561
+117,537
+1,951% +$925K ﹤0.01% 2920
2025
Q3 		$49K Buy
+6,024
New +$40K ﹤0.01% 5984
2024
Q1 		– Sell
-78,951
Closed -$204K – 8079
2023
Q4 		$186K Buy
78,951
+12,781
+19% +$23.6K ﹤0.01% 3933
2023
Q3 		$123K Buy
66,170
+26,097
+65% +$59.8K ﹤0.01% 4262
2023
Q2 		$105K Sell
40,073
-55,785
-58% -$142K ﹤0.01% 4577
2023
Q1 		$156K Buy
95,858
+41,851
+77% +$52.4K ﹤0.01% 3889
2022
Q4 		$71.8K Buy
+54,007
New +$76.2K ﹤0.01% 4722
2020
Q3 		– Sell
-2,180
Closed -$8.72K – 6603
2020
Q2 		$6K Buy
2,180
+1,700
+354% +$5.92K ﹤0.01% 5327
2020
Q1 		$1K Sell
480
-300
-38% -$1.29K ﹤0.01% 5118
2019
Q4 		$6K Hold
780
– – ﹤0.01% 4728
2019
Q3 		$8K Buy
+780
New +$8.77K ﹤0.01% 4659

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Group One Trading's XERS Position: Q2 2026 in Review

Group One Trading increased its Xeris Biopharma Holdings (XERS) stake by 3.9% in Q2 2026, buying an estimated $54K and bringing the position to 226,607 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

Group One Trading first reported a position in XERS in Q3 2019 and has held it in 13 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Group One Trading held 226,607 shares of Xeris Biopharma Holdings worth $1.79M as of Q2 2026.
  • Group One Trading bought 8,462 Xeris Biopharma Holdings shares in Q2 2026, an estimated $54K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2322 holding.
  • Group One Trading first reported a position in Xeris Biopharma Holdings in Q3 2019 and has held it in 13 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.